Client News
ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022
Destiny Pharma: Notice of R&D Update Meeting
Spexis announces positive renal impairment clinical trial results with balixafortide
CEVEC: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing
Atriva Therapeutics announces Topline Results from the Proof of Concept (POC) / Phase 2a RESPIRE study (zapnometinib) in patients hospitalized with COVID-19
ABIVAX PRESENTS FIRST-HALF 2022 FINANCIAL RESULTS AND OPERATIONS UPDATE
Newron provides H1 2022 results and updates on R&D and business activities
Marinomed to attend several upcoming investor and industry conferences
HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery
